L. Chevalet

发表

A high-throughput protein refolding screen in 96-well format combined with design of experiments to optimize the refolding conditions.

Aurélie Hermant, Aurélie Hermant, B. Antonsson, 2011, Protein expression and purification.

Demonstration of physicochemical and functional similarity between the proposed biosimilar adalimumab MSB11022 and Humira®

M. Rossi, L. Magnenat, L. Chevalet, 2016, mAbs.

Transformation of Aspergillus flavus: construction of urate oxidase-deficient mutants by gene disruption

G. Tiraby, G. Loison, L. Chevalet, 1992, Current Genetics.

Recombinant protein production driven by the tryptophan promoter is tightly controlled in ICONE 200, a new genetically engineered E. coli mutant.

T. Nguyen, J. Bonnefoy, F. Gueneau, 2000, Biotechnology and bioengineering.

In vivo processing of CXCL12α/SDF‐1α after intravenous and subcutaneous administration to mice

U. Boschert, V. Dechavanne, L. Chevalet, 2010, Proteomics.

Differences in the glycosylation of recombinant proteins expressed in HEK and CHO cells.

B. Antonsson, L. Delafosse, F. Vilbois, 2012, Journal of biotechnology.

CD4+ T-Cell-Mediated Antiviral Protection of the Upper Respiratory Tract in BALB/c Mice following Parenteral Immunization with a Recombinant Respiratory Syncytial Virus G Protein Fragment

J. Bonnefoy, A. Robert, A. Beck, 2000, Journal of Virology.

Design of Experiment in CHO and HEK transient transfection condition optimization.

V. Dechavanne, L. Chevalet, F. Bollin, 2011, Protein expression and purification.

In vivo processing of CXCL12α/SDF‐1α after intravenous and subcutaneous administration to mice

U. Boschert, V. Dechavanne, L. Chevalet, 2010, Proteomics.